1
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Antihypertensive therapy

Concepts and new agents

Pages 122-136 | Published online: 16 May 2016

Bibliography

General discussion of hypertension

  • Frohlich ED. Haemodynamics of hypertension. In: Genest J, Koiw E. Kuchel O, eds. Hypertension: physiopathology and treatment. New York: McGraw-Hill, 1977: 15–49
  • Frohlich ED. The heart in hypertension. In: Genest J, Kuchel O, Hamet P, et al, eds. Hypertension: physiopathology and treatment. 2nd ed. New York: McGraw-Hill, 1983: 791–810
  • Frohlich ED, Messerli FH, Re RN, et al. Mechanisms controlling arterial pressure. In: Frohlich ED. ed. Pathophysiology: altered regulatory mechanisms in disease. 3rd ed. Philadelphia: JB Lippincott, 1984: 45–81
  • Messerli FH, Ventura HO, Elizardi DJ, et al. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984: 77(1): 18–22
  • General discussion of antihypertensive therapy The Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. The 1984 Report of the Joint National Committee on Detection. Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1984: 144: 1045–7
  • Messerli FH, Frohlich ED. High blood pressure: a side effect of drugs, poisons, and food. Arch Intern Med 1979: 139(6): 682–7
  • Shapiro AP, Schwartz GE, Ferguson DC, et al. Behavioral methods in the treatment of hypertension. Ann Intern Med 1977: 86: 626–36
  • WHO Expat Committee on Arterial Hypertension. WHO Tech Rep Ser 628 1978

Diuretics

  • Holland OB, Nixon JV, Kuhnert L. Diuretic-induced ventricular ectopic activity. Am J Med 1981: 70(4): 762–8
  • Multicenter Diuretic Cooperative Study Group. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Arch Intern Med 1981: 141: 482–6
  • Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982: 248: 1465
  • Ram CV, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension. Ann Intern Med 1981: 141(8): 1015–9
  • Weidmann P, Keusch G, Meier A, et al. Effects of indapamide on the body sodium volume state, plasma renin, aldosterone and catecholamines, and cardiovascular pressor sensitivity in normal and borderline hypertensive man. Int Congr Ser 496 1979: 1

Beta blockers

  • Conolly ME, Kersting F, Dollery CT. The clinical pharmacology of beta-adrenoceptor-blocking drugs. Prog Cardiovasc Dis 1976: 19(3): 203–34
  • Dunn FG, Oigman W, Messerli FH, et al. Hemodynamic effects of intravenous labetalol in essential hypertension. Clin Pharmacol Ther 1983: 33(2): 139–43
  • Frohlich ED. Beta-adrenergic receptor blockade in the treatment of essential hypertension. In: Strauer BE, ed. The heart in hypertension. New York: Springer-Verlag, 1981: 425–35

Adrenergic inhibitors

  • Cambridge D, Davey MJ, Massingham R. Prazosin: a selective antagonist of post-synaptic alpha-adrenoceptors. Br J Pharmacol 1977: 59(3): 514–5
  • Fozard JR. Mechanism of the hypotensive effect of ketanserin. J Cardiovasc Pharmacol 1982: 4(5): 829–38
  • Frohlich ED. Methyldopa: mechanisms and treatment 25 years later. Arch Intern Med 1980: 140(7): 954–9
  • Van Zwieten PA. Pharmacology of centrally acting hypotensive drugs. Br J Clin Pharmacol 1980: 10(Suppl 1): 13s–20s

Vasodilators and calcium-entry blockers

  • Olivari MT, Bartorelli C, Polese A, et al. Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 1979: 59(5): 1056–62
  • Safar ME, Simon AC, Levenson JA, et al. Hemodynamic effects of diltiazem in hypertension. Circ Res 1983: 52(2 pt 2): 1169–73

Angiotensin-converting enzyme inhibitors

  • Dunn FG, Oigman W, Ventura HO, et al. Enalapril improves systemic and renal hemodynamics and regresses left ventricular mass in essential hypertension. Am J Cardiol 1984: 53: 105–8
  • Frohlich ED, Cooper RA, Lewis EJ. Review of the overall experience of captopril in hypertension. Arch Intern Med 1984: 144(7): 1441–4
  • Hollenberg NK, Meggs LG, Williams GH, et al. Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int 1981: 20(2): 240–5
  • Hricik DE, Browning PJ, Kopelman R, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 1983: 308(7): 373–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.